Sarah James
Stock Analyst at Cantor Fitzgerald
(1.95)
# 3,084
Out of 5,182 analysts
310
Total ratings
34.06%
Success rate
-7.65%
Average return
Main Sectors:
Stocks Rated by Sarah James
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TBRG TruBridge | Downgrades: Neutral | $25 → $26 | $25.77 | +1.86% | 7 | Apr 24, 2026 | |
| NYXH Nyxoah | Reiterates: Overweight | $11 | $2.99 | +267.89% | 1 | Mar 23, 2026 | |
| DCGO DocGo | Reiterates: Overweight | $3 | $0.72 | +317.83% | 9 | Mar 17, 2026 | |
| HCAT Health Catalyst | Maintains: Neutral | $4 → $3 | $1.38 | +117.39% | 9 | Mar 13, 2026 | |
| UHS Universal Health Services | Maintains: Neutral | $250 → $229 | $174.35 | +31.35% | 28 | Feb 27, 2026 | |
| MDXG MiMedx Group | Maintains: Overweight | $12 → $8 | $3.43 | +133.24% | 1 | Feb 17, 2026 | |
| HUM Humana | Maintains: Neutral | $290 → $201 | $215.23 | -6.61% | 22 | Feb 12, 2026 | |
| MOH Molina Healthcare | Maintains: Neutral | $180 → $144 | $175.94 | -18.15% | 15 | Feb 9, 2026 | |
| CNC Centene | Reiterates: Neutral | $41 | $41.82 | -1.96% | 17 | Feb 9, 2026 | |
| HCA HCA Healthcare | Maintains: Overweight | $525 → $588 | $432.46 | +35.97% | 22 | Jan 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $22 → $17 | $27.38 | -37.91% | 18 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $78 → $95 | $77.94 | +21.89% | 16 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $190 → $245 | $180.81 | +35.50% | 23 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $36 | $14.34 | +151.05% | 13 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $440 | $354.92 | +23.97% | 18 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $365 | $275.64 | +32.42% | 22 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 → $28 | $18.17 | +54.10% | 15 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $485 | $344.76 | +40.68% | 20 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $15 | $4.64 | +223.28% | 11 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $10 | $5.75 | +73.91% | 2 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $133 | $151.85 | -12.41% | 6 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $42 | $21.96 | +91.26% | 3 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $5 | $7.95 | -37.11% | 2 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $6.55 | -23.66% | 2 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $21 | $21.13 | -0.62% | 3 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $39 | $57.63 | -32.33% | 1 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $193 | $77.54 | +148.90% | 2 | Sep 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $2.72 | - | 2 | Mar 1, 2017 |
TruBridge
Apr 24, 2026
Downgrades: Neutral
Price Target: $25 → $26
Current: $25.77
Upside: +1.86%
Nyxoah
Mar 23, 2026
Reiterates: Overweight
Price Target: $11
Current: $2.99
Upside: +267.89%
DocGo
Mar 17, 2026
Reiterates: Overweight
Price Target: $3
Current: $0.72
Upside: +317.83%
Health Catalyst
Mar 13, 2026
Maintains: Neutral
Price Target: $4 → $3
Current: $1.38
Upside: +117.39%
Universal Health Services
Feb 27, 2026
Maintains: Neutral
Price Target: $250 → $229
Current: $174.35
Upside: +31.35%
MiMedx Group
Feb 17, 2026
Maintains: Overweight
Price Target: $12 → $8
Current: $3.43
Upside: +133.24%
Humana
Feb 12, 2026
Maintains: Neutral
Price Target: $290 → $201
Current: $215.23
Upside: -6.61%
Molina Healthcare
Feb 9, 2026
Maintains: Neutral
Price Target: $180 → $144
Current: $175.94
Upside: -18.15%
Centene
Feb 9, 2026
Reiterates: Neutral
Price Target: $41
Current: $41.82
Upside: -1.96%
HCA Healthcare
Jan 28, 2026
Maintains: Overweight
Price Target: $525 → $588
Current: $432.46
Upside: +35.97%
Dec 3, 2025
Maintains: Neutral
Price Target: $22 → $17
Current: $27.38
Upside: -37.91%
Oct 30, 2025
Maintains: Overweight
Price Target: $78 → $95
Current: $77.94
Upside: +21.89%
Oct 29, 2025
Maintains: Overweight
Price Target: $190 → $245
Current: $180.81
Upside: +35.50%
Oct 7, 2025
Reiterates: Overweight
Price Target: $36
Current: $14.34
Upside: +151.05%
Aug 26, 2025
Reiterates: Overweight
Price Target: $440
Current: $354.92
Upside: +23.97%
Aug 26, 2025
Reiterates: Overweight
Price Target: $365
Current: $275.64
Upside: +32.42%
Aug 8, 2025
Maintains: Overweight
Price Target: $26 → $28
Current: $18.17
Upside: +54.10%
Apr 23, 2025
Reiterates: Overweight
Price Target: $485
Current: $344.76
Upside: +40.68%
Mar 11, 2025
Reiterates: Overweight
Price Target: $15
Current: $4.64
Upside: +223.28%
Aug 20, 2024
Reiterates: Overweight
Price Target: $10
Current: $5.75
Upside: +73.91%
Mar 6, 2024
Initiates: Equal-Weight
Price Target: $133
Current: $151.85
Upside: -12.41%
Aug 22, 2023
Reiterates: Overweight
Price Target: $42
Current: $21.96
Upside: +91.26%
Sep 15, 2022
Maintains: Equal-Weight
Price Target: $6 → $5
Current: $7.95
Upside: -37.11%
Aug 19, 2022
Maintains: Overweight
Price Target: $7 → $5
Current: $6.55
Upside: -23.66%
Aug 8, 2022
Maintains: Overweight
Price Target: $14 → $21
Current: $21.13
Upside: -0.62%
Aug 12, 2021
Initiates: Overweight
Price Target: $39
Current: $57.63
Upside: -32.33%
Sep 15, 2017
Upgrades: Overweight
Price Target: $193
Current: $77.54
Upside: +148.90%
Mar 1, 2017
Downgrades: Underweight
Price Target: n/a
Current: $2.72
Upside: -